At a glance
- Originator Merck Sante
- Class Antiasthmatics; Muscle relaxants; Small molecules
- Mechanism of Action Potassium channel agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma
Most Recent Events
- 06 Jun 2001 Discontinued-Preclinical for Asthma in France (Inhalation)
- 31 Aug 1998 No-Development-Reported for Asthma in France (Inhalation)
- 04 Oct 1996 Preclinical development for Asthma in France (Inhalation)